abrdn plc Has $24.60 Million Stock Position in Aflac Incorporated (NYSE:AFL)

abrdn plc raised its holdings in Aflac Incorporated (NYSE:AFL - Free Report) by 51.2% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 298,226 shares of the financial services provider's stock after acquiring an additional 100,937 shares during the period. abrdn plc owned approximately 0.05% of Aflac worth $24,604,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Flagship Harbor Advisors LLC purchased a new stake in shares of Aflac in the 3rd quarter valued at approximately $268,000. Impact Partnership Wealth LLC boosted its position in shares of Aflac by 471.4% during the 3rd quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider's stock worth $31,000 after purchasing an additional 330 shares during the period. 1900 Wealth Management LLC purchased a new position in shares of Aflac during the 3rd quarter worth approximately $248,000. Dominguez Wealth Management Solutions Inc. boosted its position in shares of Aflac by 0.5% during the 3rd quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider's stock worth $1,916,000 after purchasing an additional 132 shares during the period. Finally, Hanlon Investment Management Inc. boosted its position in shares of Aflac by 14.7% during the 3rd quarter. Hanlon Investment Management Inc. now owns 5,987 shares of the financial services provider's stock worth $460,000 after purchasing an additional 768 shares during the period. Institutional investors and hedge funds own 67.44% of the company's stock.

Insiders Place Their Bets

In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the transaction, the director now owns 17,920 shares of the company's stock, valued at approximately $1,516,390.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the transaction, the director now owns 17,920 shares of the company's stock, valued at approximately $1,516,390.40. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Arthur Reginald Collins sold 3,000 shares of the stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $79.73, for a total value of $239,190.00. Following the transaction, the director now directly owns 5,592 shares in the company, valued at approximately $445,850.16. The disclosure for this sale can be found here. In the last three months, insiders sold 46,493 shares of company stock valued at $3,765,706. Company insiders own 0.80% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. UBS Group increased their price objective on shares of Aflac from $80.00 to $84.00 and gave the stock a "neutral" rating in a research report on Wednesday, January 10th. StockNews.com cut shares of Aflac from a "hold" rating to a "sell" rating in a research report on Wednesday, April 10th. Evercore ISI cut shares of Aflac from an "in-line" rating to an "underperform" rating and increased their price objective for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Piper Sandler increased their target price on shares of Aflac from $90.00 to $95.00 and gave the stock an "overweight" rating in a report on Friday, April 5th. Finally, The Goldman Sachs Group boosted their price target on shares of Aflac from $61.00 to $75.00 and gave the stock a "sell" rating in a research note on Tuesday, January 9th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $82.15.

Aflac Price Performance

Shares of AFL traded up $0.54 during trading hours on Wednesday, reaching $84.29. 2,431,525 shares of the company traded hands, compared to its average volume of 2,284,022. The stock has a fifty day simple moving average of $82.43 and a 200 day simple moving average of $81.68. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26. The stock has a market capitalization of $48.50 billion, a PE ratio of 10.85, a price-to-earnings-growth ratio of 2.29 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33.

Aflac (NYSE:AFL - Get Free Report) last issued its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 EPS for the quarter, missing analysts' consensus estimates of $1.47 by ($0.22). The firm had revenue of $3.78 billion for the quarter, compared to analysts' expectations of $4.44 billion. Aflac had a return on equity of 17.59% and a net margin of 24.92%. During the same quarter last year, the firm earned $1.29 earnings per share. As a group, research analysts predict that Aflac Incorporated will post 6.41 EPS for the current fiscal year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.